Surendralal Karsanbhai elected to Merck Board of Directors
With the addition of Karsanbhai, the Merck board will consist of 13 members
With the addition of Karsanbhai, the Merck board will consist of 13 members
Buckley served as Chairman and Chief Executive Officer at Vanguard from 2018 until his retirement in 2024
New Chair brings extensive experience in global pharmaceutical and biotechnology leadership, healthcare innovation, and strategic drug development
Shoff brings over 30 years of international experience in in vitro diagnostics, healthcare distribution and veterinary diagnostics
Austin assumes role from Glenn F. Tilton, who will continue to serve as an independent director
Global TB incidence saw a reduction of 8.7% while in India we were able to demonstrate a reduction of 16%, almost double the pace
Sarah currently serves as the Chief Financial Officer and Principal Accounting Officer for Criteo S.A.
Weinand is the former CEO and Chairman of the Board at Bayer Pharma AG, leading Bayer’s fully integrated $20 billion healthcare business
Dr. Hubbard brings more than 35 years of experience in the biopharmaceutical and pharma-tech services industries and CROs.
Subscribe To Our Newsletter & Stay Updated